CCDC132 is highly expressed in atopic dermatitis T cells

Area of Science:

• Genetics
• Immunology
• Molecular Biology

Background:

• Atopic dermatitis (AD) is a complex inflammatory skin disease.
• Understanding the molecular pathogenesis of AD is crucial for developing targeted therapies.
• Gene expression analysis in peripheral blood cells offers insights into disease mechanisms.

Purpose of the Study:

• To identify novel genes involved in the molecular pathogenesis of atopic dermatitis.
• To characterize the expression patterns of a newly identified gene, CCDC132, in relation to AD.

Main Methods:

• Differential display PCR was used to clone a novel gene, AB100163, highly homologous to CCDC132.
• Full-length CCDC132 cDNA was characterized.
• Western blot analysis was performed to detect the CCDC132 protein in human cell lines.
• Quantitative RT-PCR was employed to measure CCDC132 transcription levels in T cells from AD patients and healthy controls.

Main Results:

• A novel gene, AB100163, with 99% homology to coiled-coil domain containing 132 (CCDC132) was identified.
• CCDC132 mRNA is expressed in various human tissues, with high levels in brain and skeletal muscle.
• The 111 kDa CCDC132 protein was detected in human T-cell lines (MOLT-4, Jurkat) and HeLa cells.
• Quantitative RT-PCR showed significantly higher CCDC132 transcription levels in T cells from atopic dermatitis patients compared to normal individuals.

Conclusions:

• The gene CCDC132 was identified and characterized.
• Elevated CCDC132 expression in T cells of atopic dermatitis patients suggests its potential involvement in the disease's pathogenesis.
• CCDC132 represents a potential molecular target for further investigation in atopic dermatitis research.